Search research articles
Contact Us
Filters
Showing results (111-120 of 132) with videos related to
Page
of 14
Sort By:
Oncotarget
|
September 9, 2017
Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients
Mohammed Alshalalfa, Gerald W Verhaegh, Ewan A Gibb, et al.
Molecular Cancer Therapeutics
|
September 29, 2018
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer
Tilman Todenhöfer, Roland Seiler, Craig Stewart, et al.
European Urology Oncology
|
April 25, 2019
Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer
Stephen B Williams, Hogan K Hudgins, Mohamed D Ray-Zack, et al.
Surgical Oncology
|
September 6, 2020
The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group
Philipp Gild, Malte W Vetterlein, Roland Seiler, et al.
European Urology
|
March 12, 2023
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17]
Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
European Urology Focus
|
December 19, 2018
Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes
Charlotte S Voskuilen, Roland Seiler, Michael Rink, et al.
Urologic Oncology
|
September 20, 2016
Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines
Bernd J Schmitz-Dräger, Eva C Kuckuck, Tahlita C M Zuiverloon, et al.
European Urology
|
August 14, 2022
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
Genome Medicine
|
October 18, 2019
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis
Joep J de Jong, Yang Liu, A Gordon Robertson, et al.
The American Journal of Surgical Pathology
|
September 17, 2019
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma
Charlotte S Voskuilen, Htoo Zarni Oo, Vera Genitsch, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 132) with videos related to
Sort By:
Page
of 14
Oncotarget
|
September 9, 2017
Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients
Mohammed Alshalalfa, Gerald W Verhaegh, Ewan A Gibb, et al.
Molecular Cancer Therapeutics
|
September 29, 2018
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer
Tilman Todenhöfer, Roland Seiler, Craig Stewart, et al.
European Urology Oncology
|
April 25, 2019
Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer
Stephen B Williams, Hogan K Hudgins, Mohamed D Ray-Zack, et al.
Surgical Oncology
|
September 6, 2020
The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group
Philipp Gild, Malte W Vetterlein, Roland Seiler, et al.
European Urology
|
March 12, 2023
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17]
Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
European Urology Focus
|
December 19, 2018
Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes
Charlotte S Voskuilen, Roland Seiler, Michael Rink, et al.
Urologic Oncology
|
September 20, 2016
Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines
Bernd J Schmitz-Dräger, Eva C Kuckuck, Tahlita C M Zuiverloon, et al.
European Urology
|
August 14, 2022
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
Genome Medicine
|
October 18, 2019
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis
Joep J de Jong, Yang Liu, A Gordon Robertson, et al.
The American Journal of Surgical Pathology
|
September 17, 2019
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma
Charlotte S Voskuilen, Htoo Zarni Oo, Vera Genitsch, et al.
Page
of 14